Cargando…
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
BACKGROUND: Cardiovascular complications have been increasingly recognized in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated coronavirus disease 2019 (COVID-19). Cardiac biomarkers are released because of this ongoing cardiovascular injury and can act as surrogate marker...
Autores principales: | Muthyala, Anjani, Sasidharan, Sandeep, John, Kevin John, Lal, Amos, Mishra, Ajay K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523328/ https://www.ncbi.nlm.nih.gov/pubmed/36188743 http://dx.doi.org/10.5501/wjv.v11.i5.375 |
Ejemplares similares
-
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
por: Gulmez, Ali Osman, et al.
Publicado: (2023) -
Application of Microbial Bioenzymes in Soil Stabilization
por: Mekonnen, Eshetu, et al.
Publicado: (2020) -
Bioenzyme-based nanomedicines for enhanced cancer therapy
por: Ding, Mengbin, et al.
Publicado: (2022) -
Clinical considerations for critically ill COVID-19 cancer patients: A systematic review
por: Ramasamy, Chidambaram, et al.
Publicado: (2021) -
Cardiovascular complications following medical termination of pregnancy: An updated review
por: Singh, Tejveer, et al.
Publicado: (2023)